Canada's Competition Bureau says preferred provider networks may lessen competition
MLex Summary: The use of preferred provider networks, and in particular closed and mandatory PPNs appears on its face to reduce patient choice by effectively limiting the sale of certain drugs...To view the full article, register now.
Already a subscriber? Click here to view full article